anr-19

Caenorhabditis elegans

Is affected by cox-5B and nfki-1 based on RNA-seq studies.

C37H5.16

Caenorhabditis elegans

Is affected by etr-1 and cox-5B based on RNA-seq studies.

F54H5.11

Caenorhabditis elegans

Is affected by set-2 and cox-5B based on RNA-seq studies.

F57B1.10

Caenorhabditis elegans

Is affected by cox-5B; glp-1; and ilc-17.1 based on RNA-seq studies.

tat-5

Caenorhabditis elegans

Predicted to enable ATPase-coupled intramembrane lipid transporter activity. Involved in embryo development. Located in cytoplasmic vesicle and plasma membrane. Expressed widely. Is an ortholog of human ATP9B (ATPase phospholipid transporting 9B (putative)).

anr-51

Caenorhabditis elegans

Is affected by several genes including etr-1; cox-5B; and unc-70 based on RNA-seq studies.

anr-42

Caenorhabditis elegans

Is affected by several genes including etr-1; npr-8; and cox-5B based on RNA-seq studies.

anr-2

Caenorhabditis elegans

Is affected by several genes including mrps-5; cox-5B; and ogt-1 based on RNA-seq studies.

M01H9.7

Caenorhabditis elegans

Is affected by several genes including kri-1; mpk-2; and cox-5B based on RNA-seq studies.

tat-6

Caenorhabditis elegans

Predicted to enable ATPase-coupled intramembrane lipid transporter activity. Predicted to be involved in endocytosis; phospholipid translocation; and retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum. Predicted to be located in endosome; plasma membrane; and trans-Golgi network. Expressed in anterior spermathecal-uterine core cell; gonad; head; and tail. Is an ortholog of human ATP9B (ATPase phospholipid transporting 9B (putative)).